FutureLab: Prepare Your Lab Now 2018-09-19T11:37:58+00:00

FutureLab:

A Unique Interactive Strategic Planning Event for Lab Managers

Strategic Planning Experts Guide You Step-by-Step Through the Process of Developing a Complete Growth and Competitive Plan for Your Diagnostic Lab

Wednesday, October 24, 2018
Hyatt Regency Washington on Capitol Hill

Regularly $695.00 – Sale price, this week only $295.00 You save $400.00!

Number Attending:

Registration is limited to just 40 attendees. Our 1-Day Summits allow you to discuss your questions and concerns with our experts one-to-one in an intimate, non-rushed setting. Register now to secure your seat!

 

Banner Ad

Pre-conference FutureLab Summit: A Unique Interactive Strategic Planning Event for Lab Managers

What does FutureLab look like? What does your lab need to focus on to be ready to operate in a Clinical Lab 2.0 environment?

In this one-day interactive Summit, strategic planning experts and lab leaders will guide attendees step-by-step through the process of connecting trends to trajectories and developing a competitive roadmap for your diagnostic lab using Clinical Lab 2.0 ideology.

In the morning sessions, we’ll conduct an external scan and learn about the market opportunities and threats facing laboratories, such as new customers, alternative markets and revenue streams, the compliance/legal environment, and non-traditional competition. We’ll also explore emerging FutureLab technology and innovation, such as artificial intelligence and innovation in pathology.

In the afternoon, we’ll do an internal scan. Attendees will learn how to assess their own labs’ strengths and weaknesses to defend against the threats and to maximize the opportunities. And finally, we’ll connect the dots and target specific strategies you need to become a successful FutureLab. You’ll walk away with a practical Clinical Lab 2.0 toolbox to facilitate future planning.

Session Objectives:

  • Engage subject matter experts to explore external market opportunities and threats in order to paint a canvas of FutureLab;
  • Target your FutureLab opportunities based on your lab’s strengths; begin to understand your lab’s possible gaps in FutureLab; and
  • Determine action steps and target additional learning at Lab Institute 2018.

Facilitators:
Dr. James Crawford, Chair of the Department of Pathology and Laboratory Medicine, Zucker School of Medicine at Hofstra/Northwell, and Senior Vice President of Laboratory Services for the Northwell Health System
Beth Bailey, Director, Strategic Development & Communications, TriCore Reference Laboratories

Subject Matter Experts:
Lisa Jean Clifford, COO & Chief Strategy Officer, Gestalt Diagnostics
Patricia Goede, VP Clinical Informatics, XIFIN, Inc.
Julie Ramage, National Account Director, Diagnostics, Pfizer Oncology
Barb Senters, Chief Compliance & Ethics Officer, Sonic Healthcare USA
Deanna Shukis, VP Product Management, Psyche Systems
Linda L. Smith, VP Laboratory Services, SSM Health
Steven Stonecypher, Partner, Shipwright Healthcare Group
Andrew B. Wachler, Owner, Principal, Wachler & Associates, PC


Regularly $695.00 – Early bird sale price $495.00 You save $200.00 (14%)!

Number Attending:

Agenda

7:30–8:00am
Registration and Breakfast

8:00–8:25am
Why We are Here: Trends & Trajectories

8:25-8:45am
Introduction to Strategic Planning

8:45-9:45am
Conducting an External Scan: The FutureLab Market
In this facilitated work session, participants will conduct an external scan and look for the opportunities, threats, and requirements in the FutureLab market and the effects of the compliance, legal and payer environments, alternative markets and customers, and non-traditional competition.

9:45-10:00am
Networking Break

10:00-11:30am
Conducting an External Scan: FutureLab Technology & Innovation
In this facilitated work session, participants will continue to conduct an external scan, looking at the FutureLab’s opportunities, threats, and requirements in related to IT, Big Data, instrumentation, automation, machine learning, and innovation in pathology

11:30-12:30pm
Buffet Lunch

12:30-1:45pm
Conducting an Internal Scan
In this facilitated work session, participants will examine their labs’ people, technology, and processes to determine strengths and possible gaps in FutureLab.

1:45-2:00pm
Networking Break

2:00-3:15pm
Connecting the Dots
Finally, participants will use strategic planning tools and Clinical Lab 2.0 ideology to apply the data gathered throughout the session to identify possible strategic actions for FutureLab, including targeting additional learning at Lab Institute 2018.

3:15-3:30pm
Summation

Facilitators:

James M Crawford

James M Crawford, MD, PhD
Chair, Department of Pathology and Laboratory Medicine / Senior Vice President Laboratory Services at Zucker School of Medicine, Hofstra/Northwell / Northwell Health System

Dr. James Crawford is Chair of the Department of Pathology and Laboratory Medicine, Zucker School of Medicine at Hofstra/Northwell, and Senior Vice President of Laboratory Services for the Northwell Health System, a position he has held since 2009. Prior to that, for 9 years he was Chair of the Department of Pathology, Immunology and Laboratory Medicine at the University of Florida College of Medicine, Gainesville, FL. Dr. Crawford has served as Editor-in-Chief of Laboratory Investigation, President of the Association of Pathology Chairs (APC), Chair of the Council of Academic Societies of the Association of American Medical Colleges (AAMC) and member of the AAMC Board of Directors. He currently is Editor-in-Chief of the APC journal Academic Pathology. Dr. Crawford has been heavily involved in advocacy for healthcare, including chairing the Board of Directors for “PathPAC” of the College of American Pathologists. He is founding member of Project Santa Fe, which is providing leadership to drive the “Clinical Lab 2.0” movement, namely, establishing the evidence base for valuation of the clinical laboratory in the next era of American health care. This involves establishing the value statements for laboratory as a driver of both better patient outcomes and improved cost effectiveness of delivering health—and wellness—care.


Beth Bailey

Beth Bailey
Director of Strategic Development and Communications at TriCore Reference Laboratories

As Director of Strategic Development and Communications at TriCore Reference Laboratories, Beth oversees the organization’s efforts in strategic planning, project management, workforce and leadership development, succession planning, communications and public relations. Additionally, Beth actively serves on the Project Santa Fe Foundation taskforce, supporting education and communication for the Clinical Lab 2.0 initiative.

Prior to TriCore, Beth managed the corporate education and consulting program for University of New Mexico’s Anderson School of Management as a part of their Executive and Professional Education Center. Additionally, she served 15 years as a consultant with a global leadership and communication skills training company based in New York City and San Francisco, where her clients included professionals from international businesses such as Google, PwC, the Federal Reserve Bank, MedImmune, JPMorgan Chase, Cushman & Wakefield and IBM, as well as attorneys at some of the nation’s leading law firms.


Subject Matter Experts:

Lisa Jean Clifford

Lisa Jean Clifford
COO & Chief Strategy Officer at Gestalt Diagnostics

Ms. Clifford has over 20 years of experience in high-tech industries with over 15 of them specifically in healthcare high-tech.

Her experience includes strategy development and execution, general business administration and operations, marketing, business development, and product management.

She has worked in key marketing and business development roles at leading healthcare solution vendors including McKesson and IDX (GE Healthcare), past positions also include Vice President of Marketing at International Data Group (IDG) and eBusiness Technologies. Ms. Clifford is an industry expert who is widely published in business and industry trade publications; has authored a book on XML; and has presented educational and thought leadership sessions at healthcare industry conferences.

Her most recent role was CEO at Psyche Systems Corporation, a leading LIS solution and services provider, a business that she led for over ten years prior to joining Gestalt Diagnostics.


Patricia Goede

Patricia Goede

Vice President, Clinical Informatics at XIFIN, Inc.

Patricia Goede is VP Clinical Informatics at XIFIN, Inc., where she brings 22 years’ experience developing biomedical imaging informatics solutions and technology to facilitate multi-modality and multispecialty image-based exchange, collaboration, and management in distributed environments. Goede founded VisualShare and served as CEO until its acquisition by XIFIN in 2015. Previously, Goede was at the University of Utah where she pioneered a number of image, visualization and collaboration tools. She is the founder of the Electronic Medical Education Resource Group (EMERG), and as its director, established the Utah Center of Excellence for Electronic Medical Education. Goede holds an MS in Computational Visualization and a PhD. in Biomedical Imaging Informatics.


Barb Senters

Barb Senters, CCEP
Chief Compliance & Ethics Officer at Sonic Healthcare USA

Barb Senters is the Chief Compliance & Ethics Officer for Sonic Healthcare USA, a top three full service clinical lab. Her expertise lies in developing effective, risk based compliance strategies and maintaining an ethical culture with a focus on transparency. She has an extensive background in establishing and strengthening compliance programs at major health care companies. As an example, she successfully resolved the Ameritox Corporate Integrity Agreement, working closely with the Office of the Inspector General, Independent Monitor and senior leaders.

Prior to joining Sonic, Ms. Senters was the Compliance Officer for Ameritox, a toxicology lab and previously owned a consulting business called Regulatory Solutions in which she provided compliance and human resources support to colleagues in various aspects of health care. She was the Chief Compliance Officer for Solstas Lab Partners with a focus on compliance due diligence for acquisitions. She also held a Senior Compliance role at Quest Diagnostics.

She was a professional participant in developing the Office of Inspector General’s publication : “Resource Guide for Measuring Compliance Program Effectiveness”. Ms. Senters is a Certified Compliance & Ethics Professional (CCEP) and a certified Professional in Human Resources (PHR). She is also a certified Six-Sigma Greenbelt. She is an active member of the Health Care Compliance Association (HCCA) and was appointed as a “Lifetime Fellow” of the Health Ethics Trust.


Deanna Shukis

Deanna Shukis
VP Product Management at Psyche Systems

Deanna began her career at Psyche Systems Corporation in January 2013, as an Application Specialist and Trainer. Shortly after joining the organization, she assisted a team of innovative thinkers and leaders in the development and design of NucleoLIS, Molecular Information Management System (MIMS). The product serves as an industry standard for its features and functionality requirements within the molecular diagnostics laboratory.

As a visionary within the company, it was a natural progression for her to lead Product Management for the entire software application product line that Psyche has to offer.

Her experience working in the Anatomic Pathology laboratory as well as a genetic/biotechnology laboratory has allowed Deanna to help aid the development of the software features as an end user to better understand best practices for a laboratory overall.

Deanna attended the University of Rhode Island, obtained her undergraduate degree in Microbiology/Biotechnology and completed a graduate program at the University of Rhode Island and the RI School of Cytotechnology. She received an ASCP Board Certification in Cytotechnology, while working on a Master of Science in Clinical Laboratory Science.

Deanna is passionate and ambitious, not only at Psyche but at home as well. She simultaneously balances a prospering career while being a wife and mother to a baby girl and puppy.



Linda L. Smith

Linda L. Smith
Vice President Laboratory Services at SSM Health

Linda L. Smith, MHA, MT(ASCP)DLM, is Vice President, Laboratory Services for SSM Health in St. Louis, MO. She has administrative responsibility for laboratory operations in the SSM St. Louis Network’s seven hospital labs and for operations and quality lab consultations throughout the SSM system. Prior to joining SSM, Ms. Smith served as Director of Laboratory Services at GNYHA Services, Inc in New York City, NY and worked with GNYHA’s member labs on operations and contract optimization. She also worked for two years as Director of Laboratory Services at Premier, Inc in Charlotte, NC. She holds an MHA degree from the University of Arkansas in Fayetteville, AR.



Steven Stonecypher

Steven Stonecypher
Partner at Shipwright Healthcare Group

Prior to Shipwright Healthcare Group, Steve held a senior management position with American Pathology Partners, developing and deploying a patient centric value based managed care market position. He also spent a number of years at Solstas Lab Partners, developing and implementing a managed care strategy for growth for a 500M company as well as beginning his career at LabCorp where he held various positions with increasing responsibility. He holds a Bachelor of Science degree in Healthcare Administration from California State University at Long Beach and a Master of Business Administration, Finance from Houston Baptist University.


Andrew B. Wachler

Andrew B. Wachler
Owner, Principal at Wachler & Associates, PC

Andrew B. Wachler is a partner with Wachler & Associates, P.C. Mr. Wachler has been practicing healthcare law for over 30 years. He counsels healthcare providers, suppliers and organizations nationwide in a variety of healthcare legal matters. In addition, he writes and speaks nationally to professional organizations and other entities on healthcare law topics such as Medicare and third party payor appeals, Stark law and Fraud and Abuse, regulatory compliance, enrollment and revocation, and other topics. He often co-speaks with Medicare and other government officials. Mr. Wachler has met with the Centers for Medicare & Medicaid Services policy makers on numerous occasions to effectuate changes to Medicare policy and obtain fair and equitable reimbursement for health systems.

Mr. Wachler is recognized as a Fellow of State Bar of Michigan Health Care Law Section. He currently serves on the Program Planning Committee for AHLA’s Institute on Medicare and Medicaid Payment Issues. He previously served on the Editorial Board of the ABA Health Law Section publication The Health Lawyer, and has also served as Vice Chair of the ABA Health Law Section Payment and Reimbursement Interest Group, Vice Chair of the ABA Health Law Section Healthcare Policy Task Force.


Julie Ramage

Julie Ramage, National Account Director, Diagnostics
Pfizer Oncology

With over 23 years of experience in the lab industry, working for many large commercial labs in Management of Sales related roles, Julie joined Pfizer Oncology five years ago to provide subject matter expertise to their growing portfolio of therapies with companion diagnostic activities. With expansive background in pathology, technologies, platforms, reimbursement and regulatory matters, Julie has also become one of Pfizer Oncology’s primary experts in data aggregation, purchase, and evaluation within the business unit in regards to biomarkers. Julie also serves on the Board of Directors for the California Clinical Lab Association as their previous president and now as the Secretary of the board. She is involved in many organizations such as Precision Medicine Coalition, and patient advocacy groups.